142 related articles for article (PubMed ID: 31627705)
21. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
[TBL] [Abstract][Full Text] [Related]
22. Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.
Schwedler C; Kaup M; Weiz S; Hoppe M; Braicu EI; Sehouli J; Hoppe B; Tauber R; Berger M; Blanchard V
Anal Bioanal Chem; 2014 Nov; 406(28):7185-93. PubMed ID: 25234305
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
Arnold JN; Saldova R; Hamid UM; Rudd PM
Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
[TBL] [Abstract][Full Text] [Related]
24. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
25. Exploring glycans as vital biological macromolecules: A comprehensive review of advancements in biomedical frontiers.
Arora K; Sherilraj PM; Abutwaibe KA; Dhruw B; Mudavath SL
Int J Biol Macromol; 2024 May; 268(Pt 1):131511. PubMed ID: 38615867
[TBL] [Abstract][Full Text] [Related]
26. [Modification of glycoconjugates during the carcinogenesis: the case of mammary carcinomas].
Guillot J; Guerry M; Konska G; Caldefie-Chezet F; De Latour M; Penault-Llorca F
Bull Cancer; 2004 Feb; 91(2):141-58. PubMed ID: 15047454
[TBL] [Abstract][Full Text] [Related]
27. Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.
Yazawa S; Takahashi R; Yokobori T; Sano R; Mogi A; Saniabadi AR; Kuwano H; Asao T
PLoS One; 2016; 11(6):e0156277. PubMed ID: 27295180
[TBL] [Abstract][Full Text] [Related]
28. N-glycomic changes in serum proteins during human aging.
Vanhooren V; Desmyter L; Liu XE; Cardelli M; Franceschi C; Federico A; Libert C; Laroy W; Dewaele S; Contreras R; Chen C
Rejuvenation Res; 2007 Dec; 10(4):521-531a. PubMed ID: 18047421
[TBL] [Abstract][Full Text] [Related]
29. Free glycans derived from glycoproteins present in human sera.
Iwatsuka K; Watanabe S; Kinoshita M; Kamisue K; Yamada K; Hayakawa T; Suzuki T; Kakehi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():16-21. PubMed ID: 23584042
[TBL] [Abstract][Full Text] [Related]
30. Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma.
Chen J; Fang M; Zhao YP; Yi CH; Ji J; Cheng C; Wang MM; Gu X; Sun QS; Chen XL; Gao CF
PLoS One; 2015; 10(6):e0127022. PubMed ID: 26075387
[TBL] [Abstract][Full Text] [Related]
31. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
32. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
Lange T; Samatov TR; Tonevitsky AG; Schumacher U
Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
[TBL] [Abstract][Full Text] [Related]
33. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
34. Glycans and glycoproteins as specific biomarkers for cancer.
Kailemia MJ; Park D; Lebrilla CB
Anal Bioanal Chem; 2017 Jan; 409(2):395-410. PubMed ID: 27590322
[TBL] [Abstract][Full Text] [Related]
35. Greedy feature selection for glycan chromatography data with the generalized Dirichlet distribution.
Galligan MC; Saldova R; Campbell MP; Rudd PM; Murphy TB
BMC Bioinformatics; 2013 May; 14():155. PubMed ID: 23651459
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
[TBL] [Abstract][Full Text] [Related]
37. N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.
Chen J; Fang M; Chen X; Yi C; Ji J; Cheng C; Wang M; Gu X; Sun Q; Gao C
BMC Cancer; 2017 Dec; 17(1):881. PubMed ID: 29268706
[TBL] [Abstract][Full Text] [Related]
38. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
Xiao H; Suttapitugsakul S; Sun F; Wu R
Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
[TBL] [Abstract][Full Text] [Related]
39. Glycoconjugates from extracellular vesicles: Structures, functions and emerging potential as cancer biomarkers.
Costa J
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):157-166. PubMed ID: 28347750
[TBL] [Abstract][Full Text] [Related]
40. Glycosylation Profiling of Tumor Marker in Plasma Using Bead-Based Immunoassay.
Wang H; Cao Z; Duan H; Yu X
Methods Mol Biol; 2019; 1871():413-420. PubMed ID: 30276751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
